OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A new perspective on Alzheimer’s disease: microRNAs and circular RNAs
Shahidee Zainal Abidin, Nurul Asykin Mat Pauzi, Nur Izzati Mansor, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 22

Showing 22 citing articles:

Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease
Nourhan M. Abdelmaksoud, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155007-155007
Closed Access | Times Cited: 23

Alzheimer’s disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles
Seyyed Sam Mehdi Hosseininasab, Rasoul Ebrahimi, Shirin Yaghoobpoor, et al.
Frontiers in Neuroscience (2025) Vol. 18
Open Access | Times Cited: 1

Micro-RNA profiles of pathology and resilience in posterior cingulate cortex of cognitively intact elders
Christy M. Kelley, Bryan Maloney, John S. Beck, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 5

Spatiotemporal Dysregulation of Neuron–Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the 5xFAD Mouse Model of Alzheimer’s Disease
M. Di Ianni, Miriam Corraliza-Gómez, Tiago Costa-Coelho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9475-9475
Open Access | Times Cited: 4

DECIPHERING THE ROLE OF miRNAs IN ALZHEIMER'S DISEASE: PREDICTIVE TARGETING AND PATHWAY MODULATION - A SYSTEMATIC REVIEW
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Ageing Research Reviews (2024) Vol. 101, pp. 102483-102483
Closed Access | Times Cited: 4

MicroRNAs signatures as potential molecular markers in mild cognitive impairment: a meta-analysis
Natalia Vargas-Rondón, Yeimy González‐Giraldo, Angela Garcia, et al.
Frontiers in Aging Neuroscience (2025) Vol. 16
Open Access

Harnessing network pharmacology and in silico drug discovery to uncover new targets and therapeutics for Alzheimer's disease
Haitham Al‐Madhagi, Husam Nassar
Computers in Biology and Medicine (2025) Vol. 187, pp. 109781-109781
Closed Access

Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive Review
Mo‐Kyung Sin, Jeffrey L. Dage, Kwangsik Nho, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1070-1070
Open Access

Advanced Biomarkers: Beyond Amyloid and Tau: Emerging Non-Traditional Biomarkers for Alzheimer’s Diagnosis and Progression
Meher Rijwana Afrin, P. Upadhyaya, A. Hashim, et al.
Ageing Research Reviews (2025), pp. 102736-102736
Closed Access

In silico exploration of Aloe Vera leaf compounds as dual AChE and BChE inhibitors for Alzheimer’s disease therapy
Meriem Khedraoui, Fatima Zahra Guerguer, El Mehdi Karim, et al.
Current Pharmaceutical Analysis (2025)
Open Access

Exploring the complex dimensions of Alzheimer’s disease: The promising role of circular RNAs and their potential contributions
Zohreh Harsij, Zahra Mehrabi, Noushin Davoudi
Gene (2025) Vol. 960, pp. 149549-149549
Closed Access

MicroRNAs modulation by curcumin, catalpol, and other natural products in Alzheimer’s disease: a review
Amir Modarresi Chahardehi, Reza Arefnezhad, Alireza Pourbafrani, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Therapeutic Applications of Poly-miRNAs and miRNA Sponges
Cynthia Avendaño-Portugal, Mariela Montaño-Samaniego, Raquel Guttman-Bazbaz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 10, pp. 4535-4535
Open Access

Gut microbiome and Alzheimer’s disease: what we know and what remains to be explored
Bhupinder Kapoor, Pratim Biswas, Monica Gulati, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102570-102570
Closed Access | Times Cited: 3

Is Alzheimer's disease an individual-centered disease? Hypotheses from the atomic levels up to mathematical models for biological systems
Maurizio Giorelli, Donatella Accavone, Alfredo De Liso
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2

Noncoding RNAs in Alzheimer’s Disease: Overview of Functional and Therapeutic Significance
Divya Adiga, Sangavi Eswaran, Sriharikrishnaa Srinath, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1615-1634
Closed Access

Insights in RNA: 2022
Yadong Zheng, Rui Li, William C. Cho, et al.
Frontiers research topics (2024)
Open Access

POTENCIALIDADES DO MICRO RNA NA MODULAÇÃO TERAPÊUTICA E DIAGNOSTICA DA DOENÇA DE ALZHEIMER
Pedro César de Souza, Allana Fernanda de Araújo Barroso Leite, Carla Fernanda Couto Rodrigues, et al.
Revista Foco (2024) Vol. 17, Iss. 6, pp. e5283-e5283
Open Access

Expression profile of miR-214, miR-204, miR-25, miR-15a, IL-33, and plasma level of Malondialdehyde might serve as potential biomarkers for Alzheimer’s disease
Haydar Sahib Almawashee, Mohammad Khalaj‐Kondori, Mohammad Ali Hoseinpour Feizi, et al.
Research Square (Research Square) (2024)
Open Access

Page 1

Scroll to top